5 alpha-Androstane-3 beta, 17 beta-diol and 5 alpha-androstane-3 beta, 7 alpha, 17 beta-triol in the human hyperplastic prostate.
D015113:Androstane-3,17-diol / Q000031:analogs & derivatives / Q000096:biosynthesis*; D000732:Androstanols / Q000096:biosynthesis*; D015114:Androstenediol / Q000096:biosynthesis*; D000734:Androstenediols / Q000096:biosynthesis*; D002250:Carbon Radioisotopes; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D011467:Prostate / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000378:metabolism*; D011865:Radioisotope Dilution Technique; D013739:Testosterone / Q000378:metabolism*; D014316:Tritium
D000732:Androstanols; D000734:Androstenediols; D002250:Carbon Radioisotopes; D014316:Tritium; C015680:androstane-3,7,17-triol; D015113:Androstane-3,17-diol; D013739:Testosterone; D015114:Androstenediol